Impact Factor 5.511

Among the world's top 10 most-cited Immunology journals

Correction ARTICLE

Front. Immunol., 18 July 2017 | https://doi.org/10.3389/fimmu.2017.00831

Corrigendum: A Universal Influenza Vaccine Can Lead to Disease Exacerbation or Viral Control Depending on Delivery Strategies

imageCindy Bernelin-Cottet1‡, imageCharlotte Deloizy1†‡, imageOndrej Stanek2, imageCéline Barc3, imageEdwige Bouguyon1, imageCéline Urien1, imageOlivier Boulesteix3, imageJérémy Pezant3, imageCharles-Adrien Richard1, imageMohammed Moudjou1, imageBruno Da Costa1, imageLuc Jouneau1, imageChristophe Chevalier1, imageClaude Leclerc4,5, imagePeter Sebo2, imageNicolas Bertho1 and imageIsabelle Schwartz-Cornil1*
  • 1VIM-INRA-Université Paris-Saclay, Jouy-en-Josas, France
  • 2Institute of Microbiology of the Czech Academy of Sciences, v.v.i, Prague, Czech Republic
  • 3INRA, UE1277, Plate-Forme d’Infectiologie Expérimentale PFIE, Nouzilly, France
  • 4Institut Pasteur, Unité de Régulation Immunitaire et Vaccinologie, Equipe Labellisée Ligue Contre le Cancer, Paris, France
  • 5INSERM U1041, Unité de Régulation Immunitaire et Vaccinologie, Département Immunologie, Paris, France

A corrigendum on

A Universal Influenza Vaccine Can Lead to Disease Exacerbation or Viral Control Depending on Delivery Strategies
by Bernelin-Cottet C, Deloizy C, Stanek O, Barc C, Bouguyon E, Urien C, et al. Front Immunol (2016) 7:641. doi:10.3389/fimmu.2016.00641

In the original article, there was an error in the CpG oligo-dinucleotide sequence used as adjuvant.

A correction has been made to the section “Materials and Methods”, paragraph “Antibodies and adjuvants”: CpG oligo-dinucleotides 5′-ggTGCATCGATTTATCGATTATCGATGCAGggggg-3′ with lower case letters for phosphorothioate linkages and upper case letters for phosphodiester linkages previously shown to be efficient in pigs (26) were bought from Sigma.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

Conflict of Interest Statement

CL, PS, and OS are inventors of the issued patent “A versatile delivery system for antigens or biologically active molecules.” EP 09290987.8-1222, 21.12.09. No license nor royalties. The other authors declare no conflict of interest.

Keywords: dendritic cells, swine, human, vaccines, routes of administration

Citation: Bernelin-Cottet C, Deloizy C, Stanek O, Barc C, Bouguyon E, Urien C, Boulesteix O, Pezant J, Richard C-A, Moudjou M, Costa BD, Jouneau L, Chevalier C, Leclerc C, Sebo P, Bertho N and Schwartz-Cornil I (2017) Corrigendum: A Universal Influenza Vaccine Can Lead to Disease Exacerbation or Viral Control Depending on Delivery Strategies. Front. Immunol. 8:831. doi: 10.3389/fimmu.2017.00831

Received: 23 June 2017; Accepted: 30 June 2017;
Published: 18 July 2017

Edited and Reviewed by: José Mordoh, Fundación Instituto Leloir, Argentina

Copyright: © 2017 Bernelin-Cottet, Deloizy, Stanek, Barc, Bouguyon, Urien, Boulesteix, Pezant, Richard, Moudjou, Costa, Jouneau, Chevalier, Leclerc, Sebo, Bertho and Schwartz-Cornil. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Isabelle Schwartz-Cornil, isabelle.schwartz@inra.fr

Present address: Charlotte Deloizy, GenoSafe, Evry, France

These authors have equally contributed to this work.